Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2015
Number of items: 4.

2015

Freeman, C., Dixon, M., Houghton, R., Humphrey, K., Fingerle-Rowson, G., Kreuzer, K. A., Engelke, A., Hallek, M. and Goede, V. (2015). Risk factors associated with the development of infusion-related reactions (IRRs) in patients with chronic lymphocytic leukaemia (CLL) treated with anti-CD20 monoclonal antibodies (mAbs) in combination with chlorambucil: analysis of the prospective, randomised phase III CLL11 study dataset. Br. J. Haematol., 169. S. 63 - 64. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Freeman, C., Dixon, M., Houghton, R., Humphrey, K., Fingerle-Rowson, G., Kreuzer, K. A., Engelke, A., Hallek, M. and Goede, V. (2015). Risk factors associated with the development of infusion-related reactions (IRRs) in patients with chronic lymphocytic leukaemia (CLL) treated with anti-CD20 monoclonal antibodies (mAbs) in combination with chlorambucil: analysis of the prospective, randomised phase III CLL11 study dataset. Br. J. Haematol., 169. S. 63 - 64. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Freeman, C., Morschhauser, F., Sehn, L., Dixon, M., Houghton, R., Lamy, T., Fingerle-Rowson, G., Wassner-Fritsch, E., Hallek, M., Salles, G. and Cartron, G. (2015). Pattern of cytokine release in patients with chronic lymphocytic leukaemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR). Br. J. Haematol., 169. S. 64 - 65. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Freeman, C., Morschhauser, F., Sehn, L., Dixon, M., Houghton, R., Lamy, T., Fingerle-Rowson, G., Wassner-Fritsch, E., Hallek, M., Salles, G. and Cartron, G. (2015). Pattern of cytokine release in patients with chronic lymphocytic leukaemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR). Br. J. Haematol., 169. S. 64 - 65. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

This list was generated on Sat Apr 27 16:51:53 2024 CEST.